Oncolytic Virotherapy Summit 2017

Kongressthemen
The Oncolytic Virotherapy Summit will gather the leaders in immuno-oncolytic virus development to discuss the most up-to-date clinical advances alongside novel innovations being made through the genetic modification of viruses.

Map out the route to market focusing on the strategic advancements needed to improve viral manufacturing yield and scale along with the operational and logistical aspects of delivering oncolytic virotherapies to patients in need.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/158062-1

Speakers: Matt Mulvey (Benevir Biopharm), Charles Morris (PsiOxus Therapeutics), Stephen Thorne (Western Oncolytics), Frank Tufaro (DNAtrix), Stephen Russell (Vyriad), Angelica Loskog (Lokon Pharma)

http://go.evvnt.com/158062-0

Customer Services